March 30, 2020 / By James Rogers | Fox News Biotech company Gilead Sciences is expanding access to its antiviral drug remdesivir as an experimental coronavirus treatment. In an open letter sent out Saturday, Gilead CEO Daniel O’Day said the company is carefully ramping up its efforts to make remdesivir available to coronavirus patients. The antiviral has previously been used to treat …